Iodoacetamide

Iodoacetamide

SCHEMBL21543897

NC(=O)CI.O=C(CI)N1CCOCC1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ KDM4E B2RXH2 3/20 0.50
▸ TSHR P16473 3/20 0.48
▸ ALOX15 P16050 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ POLB P06746 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ GLA P06280 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ TP53 P04637 2/20 0.46
▸ GMNN O75496 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ THPO P40225 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2262931 0.91 L3MBTL1 (0.61) L3MBTL1TSHRALOX15HSD17B10POLB
SCHEMBL3466247 0.81 L3MBTL1 (0.55) L3MBTL1KDM4ETSHRALOX15HSD17B10
SCHEMBL6233242 0.79 TSHR (0.56) L3MBTL1KDM4ETSHRALOX15HSD17B10
SCHEMBL423999 0.78 L3MBTL1 (0.61) L3MBTL1TSHRALOX15HSD17B10POLB
SCHEMBL20520314 0.78 GLA (0.64) L3MBTL1KDM4ETSHRALOX15HSD17B10
Hydrochloric Acid SCHEMBL30405920 0.78 POLB (0.54) L3MBTL1KDM4ETSHRALOX15HSD17B10
SCHEMBL10870 0.77 L3MBTL1 (0.55) L3MBTL1TSHRALOX15HSD17B10POLB
SCHEMBL9275712 0.77 ALDH1A1 (0.48) L3MBTL1KDM4ETSHRALOX15HSD17B10
SCHEMBL24313327 0.76 L3MBTL1 (0.78) L3MBTL1TSHRALOX15HSD17B10POLB
SCHEMBL1303142 0.76 L3MBTL1 (0.59) L3MBTL1TSHRALOX15HSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10969394-B2 Reagents and methods for analysis of proteins and metabolites targeted by covalent probes DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-04-06 — — US disclosed
US-20190346454-A1 Reagents and Methods for Analysis of Proteins and Metabolites Targeted by Covalent Probes DANA-FARBER CANCER INSTITUTE, INC. 2019-11-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10969394-B2 Reagents and methods for analysis of proteins and metabolites targeted by covalent probes PTMS, SRMS, HSP90B1 L3MBTL1 1091/4885KDM4E 3804/4885TSHR 3733/4885
US-20190346454-A1 Reagents and Methods for Analysis of Proteins and Metabolites Targeted by Covalent Probes PTMS, SRMS, HSP90B1 L3MBTL1 1091/4885KDM4E 3804/4885TSHR 3733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback